Memantine as an Additive Therapy in Patients With Traumatic Brain Injury

Summary

Memantine has shown promise in mitigating secondary brain injury in previous studies. One study demonstrated that early memantine administration in moderate TBI patients resulted in lower serum neuron-specific enolase levels and improved Glasgow Coma Scale scores. However, other trials investigating memantine's impact on long-term cognitive function in TBI patients have yielded mixed results. There is a need for well-controlled studies to determine the efficacy of memantine in improving neurological and cognitive outcomes in patients with TBI.

Timeline

Start

2025-03-25

Primary completion

2025-08-30

Completion

2025-11-30

Drugs

Indications